VERTEX PHARMACEUTICALS INC / MA·4

Feb 18, 4:39 PM ET

Sachdev Amit 4

Research Summary

AI-generated summary

Updated

Vertex (VRTX) EVP Amit Sachdev Surrenders 3,548 Shares for Taxes

What Happened

  • Amit Sachdev, EVP and Chief Patient & External Affairs Officer at Vertex Pharmaceuticals (VRTX), had 3,548 shares disposed on 2026-02-13 as payment to cover tax liability. The shares were valued at $487.76 each for a total of approximately $1,730,572.
  • This was a share withholding to satisfy tax obligations (not an open-market sale), a routine administrative step following an equity award or option exercise.

Key Details

  • Transaction date: 2026-02-13. Price per share: $487.76. Total value: ~$1,730,572.
  • Transaction type/code: F — payment of exercise price or tax liability (shares withheld).
  • Shares owned after the transaction: not provided in the summary data here; see the SEC Form 4 for the insider’s reported holdings.
  • Filing date: 2026-02-18 (five days after the transaction). Form 4s are normally due within two business days of the transaction; this filing appears later than that window—see the full filing for any timeliness notes or explanations.

Context

  • Withheld shares used to pay taxes are common after option exercises or restricted stock vesting and generally reflect routine tax withholding rather than a decision to liquidate shares on the open market.
  • For a complete picture (current holdings, whether this was tied to a specific grant/exercise, and any 10b5-1 plan or additional footnotes), consult the full SEC Form 4 (Accession: 0000875320-26-000074).